Phase 2 Study of EPI-743 in Children With Pearson Syndrome
Clinical trial NCT02104336 · TERMINATED
Trial details
- NCT number
- NCT02104336
- Sponsor
- Edison Pharmaceuticals Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-31
- Primary completion
- 2015-11-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.